These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16306341)

  • 21. A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion.
    Bonifacio E; Krumsiek J; Winkler C; Theis FJ; Ziegler AG
    Acta Diabetol; 2014; 51(3):403-11. PubMed ID: 24249616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Leukocyte Antigen (HLA) and Islet Autoantibodies Are Tools to Characterize Type 1 Diabetes in Arab Countries: Emphasis on Kuwait.
    Jahromi M; Al-Ozairi E
    Dis Markers; 2019; 2019():9786078. PubMed ID: 31827651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study.
    Kukko M; Kimpimäki T; Kupila A; Korhonen S; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
    Diabetologia; 2003 Jan; 46(1):65-70. PubMed ID: 12637984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes.
    Mayr A; Schlosser M; Grober N; Kenk H; Ziegler AG; Bonifacio E; Achenbach P
    Diabetes; 2007 Jun; 56(6):1527-33. PubMed ID: 17325256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural history of type 1 diabetes.
    Achenbach P; Bonifacio E; Koczwara K; Ziegler AG
    Diabetes; 2005 Dec; 54 Suppl 2():S25-31. PubMed ID: 16306336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
    Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
    Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IA-2 autoantibody affinity in children at risk for type 1 diabetes.
    Krause S; Chmiel R; Bonifacio E; Scholz M; Powell M; Furmaniak J; Rees Smith B; Ziegler AG; Achenbach P
    Clin Immunol; 2012 Dec; 145(3):224-9. PubMed ID: 23110943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
    van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
    J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies.
    Miao D; Yu L; Tiberti C; Cuthbertson DD; Rewers M; di Mario U; Eisenbarth GS; Dotta F
    J Autoimmun; 2002 Mar; 18(2):191-6. PubMed ID: 11908951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
    Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
    Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
    Tiberti C; Giordano C; Locatelli M; Bosi E; Bottazzo GF; Buzzetti R; Cucinotta D; Galluzzo A; Falorni A; Dotta F
    Diabetes; 2008 May; 57(5):1276-83. PubMed ID: 18332100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood.
    Roll U; Christie MR; Füchtenbusch M; Payton MA; Hawkes CJ; Ziegler AG
    Diabetes; 1996 Jul; 45(7):967-73. PubMed ID: 8666150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble adhesion molecules in young children with signs of beta-cell autoimmunity--prospective follow-up from birth.
    Toivonen AM; Kimpimäki T; Kupila A; Korhonen S; Hyöty H; Virtanen SM; Ilonen J; Simell O; Knip M
    Diabetes Metab Res Rev; 2006; 22(3):176-83. PubMed ID: 16270299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Islet Autoantibodies.
    Lampasona V; Liberati D
    Curr Diab Rep; 2016 Jun; 16(6):53. PubMed ID: 27112957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes.
    Kawasaki E; Yu L; Rewers MJ; Hutton JC; Eisenbarth GS
    Diabetes; 1998 May; 47(5):733-42. PubMed ID: 9588444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Latent autoimmune diabetes in adults].
    Maioli M; Puddu L; Pes GM
    Clin Ter; 2006; 157(1):69-78. PubMed ID: 16669554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes.
    Mäkinen A; Härkönen T; Ilonen J; Knip M;
    Eur J Endocrinol; 2008 Jul; 159(1):19-26. PubMed ID: 18573919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between IA-2 autoantibody epitope specificities and age of onset in Japanese patients with autoimmune diabetes.
    Kawasaki E; Sera Y; Fujita N; Yamauchi M; Ozaki M; Abe T; Yamakawa K; Uotani S; Takino H; Yamasaki H; Yamaguchi Y; Uchigata Y; Matsuura N; Eguchi K
    J Autoimmun; 2001 Dec; 17(4):323-31. PubMed ID: 11771957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase.
    Syren K; Lindsay L; Stoehrer B; Jury K; Lühder F; Baekkeskov S; Richter W
    J Immunol; 1996 Dec; 157(11):5208-14. PubMed ID: 8943434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.